Works matching IS 0012186X AND DT 2009 AND VI 52 AND IP 11


Results: 29
    1
    2

    Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

    Published in:
    Diabetologia, 2009, v. 52, n. 11, p. 2328, doi. 10.1007/s00125-009-1484-7
    By:
    • Galan, B.;
    • Zoungas, S.;
    • Chalmers, J.;
    • Anderson, C.;
    • Dufouil, C.;
    • Pillai, A.;
    • Cooper, M.;
    • Grobbee, D.;
    • Hackett, M.;
    • Hamet, P.;
    • Heller, S.;
    • Lisheng, L.;
    • MacMahon, S.;
    • Mancia, G.;
    • Neal, B.;
    • Pan, C.;
    • Patel, A.;
    • Poulter, N.;
    • Travert, F.;
    • Woodward, M.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Intensive glucose control and macrovascular outcomes in type 2 diabetes.

    Published in:
    Diabetologia, 2009, v. 52, n. 11, p. 2288, doi. 10.1007/s00125-009-1470-0
    By:
    • Turnbull, F.;
    • Abraira, C.;
    • Anderson, R.;
    • Byington, R.;
    • Chalmers, J.;
    • Duckworth, W.;
    • Evans, G.;
    • Gerstein, H.;
    • Holman, R.;
    • Moritz, T.;
    • Neal, B.;
    • Ninomiya, T.;
    • Patel, A.;
    • Paul, S.;
    • Travert, F.;
    • Woodward, M.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    29